BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruzic D, Djoković N, Srdić-rajić T, Echeverria C, Nikolic K, Santibanez JF. Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention. Pharmaceutics 2022;14:209. [DOI: 10.3390/pharmaceutics14010209] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Nakagawa-saito Y, Saitoh S, Mitobe Y, Sugai A, Togashi K, Suzuki S, Kitanaka C, Okada M. HDAC Class I Inhibitor Domatinostat Preferentially Targets Glioma Stem Cells over Their Differentiated Progeny. IJMS 2022;23:8084. [DOI: 10.3390/ijms23158084] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 An T, Lu Y, Yan X, Hou J. Insights Into the Properties, Biological Functions, and Regulation of USP21. Front Pharmacol 2022;13:944089. [DOI: 10.3389/fphar.2022.944089] [Reference Citation Analysis]
3 Shu Y, Huang C, Liu H, Hu F, Wen H, Liu J, Wang X, Shan C, Li W. A hemicyanine-based fluorescent probe for simultaneous imaging of Carboxylesterases and Histone deacetylases in hepatocellular carcinoma. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2022. [DOI: 10.1016/j.saa.2022.121529] [Reference Citation Analysis]
4 Alsayed RKME, Khan AQ, Ahmad F, Ansari AW, Alam MA, Buddenkotte J, Steinhoff M, Uddin S, Ahmad A. Epigenetic Regulation of CXCR4 Signaling in Cancer Pathogenesis and Progression. Semin Cancer Biol 2022:S1044-579X(22)00075-X. [PMID: 35346802 DOI: 10.1016/j.semcancer.2022.03.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]